EffecTrial: Fostering Pragmatic Comparative-Effectiveness Trials in Non-communicable Diseases


The Partnership “Fostering a European Research Area for Health” (ERA4Health) aims at establishing a flexible and effective coordination between funding organisations in the European Research Area (ERA) in priority areas addressing European Public Health Needs.

This Partnership brings the opportunity to increase European transnational collaborative research funding by creating a funding body for joint programming. Under this umbrella, ERA4Health is glad to pre-announce the launch of a first Joint Transnational Call (JTC) in multi-country Investigator-Initiated Clinical Studies (IICS) on “Fostering Pragmatic Comparative-Effectiveness Trials in Non-communicable Diseases” (EffecTrial).

We kindly remind you that ERA4Health has planned on November 11th a dedicated webinar focused on these types of clinical studies in which our invited speaker Dr. Frank Hulstaert, M.D., Senior Researcher at the Belgian Health Care Knowledge Centre (KCE) will present a discussion on “Pragmatic Comparative-Effectiveness Randomized Trials: Real-World Evidence for Better Health Decisions.

EffecTrial

ERA4Health JTC5 IICS EffecTrial Pre-announcement (Download)


Call Timeline

Call Pre-announcement 21 October 2024
Publication of EffectTrial call 20 November 2024
Webinar Infoday 27 November 2024 (to be confirmed)
Deadline for pre-proposal submission 28 January 2025
Communication of the results of the pre-proposal assessment (invitation for full proposal) 15 April, 2025
Deadline for the submission of invited Full-proposals 17 June, 2025
Rebuttal stage 25 August – 5 September, 2025
Communication of the funding decisions to the applicants End of October, 2025
Expected project start (subject to national procedures) January – May 2026

Further information

Joint Call Secretariat (JCS) - Astrid Valencia Quiñónez and Sara García-Rodríguez EffecTrial@isciii.es

Please note: The content of the call described in this pre-announcement is indicative and may be subject to changes and is not legally binding. Interested applicants are encouraged to initiate scientific contacts with potential project consortium partners for applications.